Hermanus  Kieftenbeld net worth and biography

Hermanus Kieftenbeld Biography and Net Worth

CFO of Amyris
Han Kieftenbeld joined Amyris as Chief Financial Officer in March 2020 and was appointed Chief Administration Officer in July 2020. He brings over 25 years of international business leadership, finance and operations experience in food, health and nutrition end-markets. Most recently, from April 2016 to April 2019, Mr. Kieftenbeld served as Senior Vice President and Chief Financial Officer of Innophos Holdings, Inc., a leading international science-based producer of essential ingredients for health and nutrition, food and beverage and industrial brands. From June 2014 to July 2015, Mr. Kieftenbeld served as the Global Chief Financial Officer at AB Mauri, a worldwide leader in bakery ingredients. Prior to that, Mr. Kieftenbeld held finance and operations roles of increasing reach and impact, including serving as Global Chief Procurement Officer of Ingredion Incorporated, and Global Chief Financial Officer of National Starch. Mr. Kieftenbeld started his career at Unilever in the Netherlands. In 2006, Mr. Kieftenbeld earned a joint master’s degree from New York University Stern School of Business, London School of Economics and Political Science, and the HEC School of Management, Paris. He holds a B.S. in Business Economics and Accounting from Windesheim University in the Netherlands.

What is Hermanus Kieftenbeld's net worth?

The estimated net worth of Hermanus Kieftenbeld is at least $0.00 as of June 2nd, 2023. Mr. Kieftenbeld owns 219,768 shares of Amyris stock worth more than $0 as of November 4th. This net worth estimate does not reflect any other investments that Mr. Kieftenbeld may own. Additionally, Mr. Kieftenbeld receives a salary of $644,710.00 as CFO at Amyris. Learn More about Hermanus Kieftenbeld's net worth.

How old is Hermanus Kieftenbeld?

Mr. Kieftenbeld is currently 57 years old. There are 3 older executives and no younger executives at Amyris. The oldest executive at Amyris is Ms. Elizabeth E. Dreyer CPA, Chief Accounting Officer & Corp. Controller, who is 61 years old. Learn More on Hermanus Kieftenbeld's age.

What is Hermanus Kieftenbeld's salary?

As the CFO of Amyris, Inc., Mr. Kieftenbeld earns $644,710.00 per year. The highest earning executive at Amyris is Mr. Eduardo Alvarez, Chief Operating Officer, who commands a salary of $687,620.00 per year. Learn More on Hermanus Kieftenbeld's salary.

How do I contact Hermanus Kieftenbeld?

The corporate mailing address for Mr. Kieftenbeld and other Amyris executives is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. Amyris can also be reached via phone at (510) 450-0761 and via email at [email protected]. Learn More on Hermanus Kieftenbeld's contact information.

Has Hermanus Kieftenbeld been buying or selling shares of Amyris?

Hermanus Kieftenbeld has not been actively trading shares of Amyris during the past quarter. Most recently, Hermanus Kieftenbeld sold 20,999 shares of the business's stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $0.95, for a transaction totalling $19,949.05. Following the completion of the sale, the chief financial officer now directly owns 219,768 shares of the company's stock, valued at $208,779.60. Learn More on Hermanus Kieftenbeld's trading history.

Who are Amyris' active insiders?

Amyris' insider roster includes Eduardo Alvarez (COO), Anthony Hughes (CAO), Nicole Kelsey (Insider), Hermanus Kieftenbeld (CFO), Frank Kung (Director), James McCann (Director), and John Melo (CEO). Learn More on Amyris' active insiders.

Hermanus Kieftenbeld Insider Trading History at Amyris

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2023Sell20,999$0.95$19,949.05219,768View SEC Filing Icon  
6/2/2022Sell34,905$2.34$81,677.70266,655View SEC Filing Icon  
9/2/2021Sell24,380$14.86$362,286.80View SEC Filing Icon  
See Full Table

Hermanus Kieftenbeld Buying and Selling Activity at Amyris

This chart shows Hermanus Kieftenbeld's buying and selling at Amyris by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amyris Company Overview

Amyris logo
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.54
Low: $0.05
High: $1.17

2 Week Range

Now: N/A

Volume

46,746,000 shs

Average Volume

12,593,118 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19